Sudo Bio
4 known investors
Sudo Biosciences discovers and develops small-molecule medicines, including next-generation TYK2 inhibitors, for serious neurological and immunological conditions such as multiple sclerosis and immune-mediated inflammatory diseases. It focuses on medicinal chemistry, translational biology, and patient-centered drug development.
BiotechHealthtech
Investors · 4
In the news
Frequently asked questions
- What does Sudo Bio do?
- Sudo Biosciences discovers and develops small-molecule medicines, including next-generation TYK2 inhibitors, for serious neurological and immunological conditions such as multiple sclerosis and immune-mediated inflammatory diseases. It focuses on medicinal chemistry, translational biology, and patient-centered drug development.
- Who are Sudo Bio's investors?
- Sudo Bio's investors include Frazier Life Sciences, Monograph Capital Partners, Sanofi Ventures, Dementia Discovery Fund.